arrow
S

Stephen G. Swisher

University of Texas MD Anderson Cancer Center
H指数:110
被引数:4.6万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Development and validation of a short version of the MD Anderson Symptom Inventory for upper gastrointestinal surgery (short-MDASI-UGI-Surg) for postoperative patient-reported outcome-based care

MD Anderson 症状清单上消化道手术短版(short-MDASI-UGI-Surg)的开发与验证:基于术后患者报告结局的护理

2026-04-010
PRE
Patient-Reported Symptom Recovery After Upper Gastrointestinal Cancer Surgery: A Prospective Study Using the MDASI-UGI-Surg

上消化道癌术后患者报告的症状恢复:一项使用MDASI-UGI-Surg的前瞻性研究

2026-02-190
OAAI
Training left-handed cardiothoracic surgeons in a right-handed world: Perspectives, experiences, and educational opportunities

在右手习惯的世界中培养左撇子心胸外科医生:观点、经验和教育机会

2026-02-010
OAAI
Multimodal spatial-omics reveal co-evolution of alveolar progenitors and proinflammatory niches in progression of lung precursor lesions

多模态空间组学揭示肺前驱病变进展过程中肺泡祖细胞与促炎微环境的协同进化

2025-11-060
OAAI
Psychometric Validation of a new module of MD Anderson Symptom Inventory (MDASI) for Patients with Upper Gastrointestinal Cancers: MDASI-UGI-Surg

MD Anderson症状清单(MDASI)新模块的心理测量学验证:适用于上消化道癌患者的MDASI-UGI-Surg模块

2025-10-070
PRE
Machine Learning Prediction of Financial Toxicity in Patients with Resected Lung Cancer

基于机器学习的肺癌切除术后患者经济毒性预测

2025-07-160
PRE
Extent of resection in surgically resected stage IV non−small cell lung cancer: Results from two tertiary referral centers

手术切除的Ⅳ期非小细胞肺癌的切除范围:来自两家三级转诊中心的结果

2025-04-230
PRE
High peripheral T cell diversity is associated with lower risk of toxicity and superior response to dual immune checkpoint inhibitor therapy in patients with metastatic NSCLC
2024-12-250
OAAI
CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors

CTLA4阻断消除KEAP1/STK11-related对PD-(L)1抑制剂的抗性

Nature
IF48.5
2024-10-090
OAAI
Multimodal spatial transcriptomics and proteomics analysis of the resectable NSCLC ecosystem following neoadjuvant chemoimmunotherapy
2024-03-220
PRE